Penicillamine as a potent protector against injurious effects of cigarette smoke in aerodigestive tract cancer

Oncology

Volumn 78, Issue 1, 2010, Pages 12-19

  Nagler, Rafael ^a   Cohen, Shiri ^a   Savulescu, Dana ^a   Leschiner, Svetlana ^a   Otradnov, Irina ^a   Gavish, Moshe ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cigarette smoke; Free radicals; Lung cancer; Oral cancer; Penicillamine; Saliva

Indexed keywords

CARBONYL DERIVATIVE; COPPER; DEFEROXAMINE MESYLATE; IRON; PENICILLAMINE; PROTEIN P53;

ADULT; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL LOSS; CELL PROTECTION; CHELATION; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUTH CANCER; OXIDATION REDUCTION REACTION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SALIVA; SURVIVAL RATE;

ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; LUNG NEOPLASMS; MOUTH NEOPLASMS; PENICILLAMINE; SALIVA; SMOKE; SMOKING;

EID: 77949901833     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000287967     Document Type: Article

References (26)

1. World Health Organization: World Cancer Day: global action to avert 8 million cancerrelated deaths by 2015. Washington, WHO, 2006.
2. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, Salo T: Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-619.
3. Myers JN, Elkins T, Roberts D, Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51.
4. Ribeiro KC, Kowalski LP, Latorre MR: Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000; 126: 1079-1085.
5. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB: Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004; 26: 984-994.
6. Hasnis E, Reznick AZ, Pollack S, Klein I, Nagler RM: Synergistic effect of cigarette smoke and saliva on lymphocytes - the mediatory role of volatile aldehydes and redox active iron and the possible implication for oral cancer. Int J Biochem Cell Biol 2004; 36: 826-839.
7. Reznick AZ, Hershkovich O, Nagler RM: Saliva - a pivotal player in the pathogenesis of oropharyngeal cancer. Br J Cancer 2004; 91: 111-118.
8. Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick AZ: Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys 2000; 379: 229-236.
9. Nagler RM, Marmary Y, Fox PC, Baum BJ, Har-El R, Chevion M: Irradiation-induced damage to the salivary glands: the role of redox- active iron and copper. Radiat Res 1997; 147: 468-475.
10. Teken F, Mungan D, Sayal A, Misurligil Z, Aydin A, Gürbüz L, Isimer A, Demirel YS, Acican T, Sin B: Serum and pleural fluid selenium, copper, zinc, and magnesium levels in malignant and nonmalignant pleural diseases. Respiration 1996; 63: 25-27.
11. Gutteridge JMC, Mumby S, Quinlan GJ, Chung KF, Evans TW: Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun 1996; 220: 1024-1027.
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254.
13. Levine RL, Williams JA, Stadtman ER, Shacter E: Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233: 346-357.
14. Kugler W, Veenman L, Shandalov Y, Leschiner S, Spanier I, Lakomek M, Gavish M: Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 2008; 30: 435-450.
15. Vayssier-Taussat M, Camilli T, Aron Y, Meplan C, Hainaut P, Polla BS, Weksler B: Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am J Physiol Heart Circ Physiol 2001; 280:H1293-H1300.
16. Banzet N, François D, Polla BS: Tobacco smoke induces mitochondrial depolarization along with cell death: effects of antioxidants. Redox Rep 1999; 4: 229-236.
17. Smith CJ, Perfetti TA, King JA: Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 2006; 18: 667-677.
18. Feng Z, Hu W, Hu Y, Tang MS: Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA 2006; 103: 15404-15409.
19. Hainaut P, Rolley N, Davies M, Milner J: Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 1995; 10: 27-32.
20. Hainaut P, Milner J: Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993; 53: 4469-4473.
21. Singh IN, Sullivan PG, Hall ED: Peroxynitrite- mediated oxidative damage to brain mitochondria: protective effects of peroxynitrite scavengers. J Neurosci Res 2007; 85: 2216-2223.
22. Font L, Aragon CM, Miquel M: Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D - penicillamine, an inactivation agent for acetaldehyde. Psychopharmacology (Berl) 2006; 184: 56-64.
23. Wood PL, Khan MA, Moskal JR: Mechanism of action of the disease-modifying anti-arthritic thiol agents D -penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes. Eur J Pharmacol 2008; 580: 48-54.
24. Munro R, Capell HA: Penicillamine. Br J Rheumatol 1997; 36: 104-109.
25. Mossman BT, Lounsbury KM, Reddy SP: Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 2006; 34: 666-669.
26. Yu Y, Wong J, Lovejoy DB, Kalinowski DS, Richardson DR: Chelators at the cancer coalface: desferrioxamine to triapine and beyond. Clin Cancer Res 2006; 12: 687-688.